Managing diabetes in dialysis patients

Postgraduate Medical Journal

Volumn 88, Issue 1037, 2012, Pages 160-166

  O'Toole, Sam M ^a   Fan, Stanley L ^a   Yaqoob, M Magdi ^a   Chowdhury, Tahseen A ^a  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; ACARBOSE; BIGUANIDE DERIVATIVE; DIPEPTIDYL PEPTIDASE IV INHIBITOR; GLITAZONE DERIVATIVE; GLUCAGON LIKE PEPTIDE 1 DERIVATIVE; GLUCOSE; HEMOGLOBIN A1C; ICODEXTRIN; INSULIN; MEGLITINIDE; SULFONYLUREA;

ADAPTIVE IMMUNITY; ARTICLE; BLOOD GLUCOSE METER; BLOOD GLUCOSE MONITORING; CARDIOVASCULAR DISEASE; DIABETES MELLITUS; DIABETIC FOOT; DIABETIC RETINOPATHY; DIALYSIS; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HEMODIALYSIS; HEMODIALYSIS PATIENT; HUMAN; HYPERGLYCEMIA; HYPOGLYCEMIA; INFECTION; KIDNEY FAILURE; LEG AMPUTATION; MALNUTRITION; MORBIDITY; MORTALITY; PERIPHERAL NEUROPATHY; PERITONEAL DIALYSIS; QUALITY OF LIFE; SEPTICEMIA;

DIABETES MELLITUS; DISEASE MANAGEMENT; HUMANS; HYPERGLYCEMIA; KIDNEY FAILURE, CHRONIC; RENAL DIALYSIS; RISK REDUCTION BEHAVIOR;

EID: 84857195570     PISSN: 00325473     EISSN: 14690756     Source Type: Journal    
DOI: 10.1136/postgradmedj-2011-130354     Document Type: Article

References (75)

1. Diabetes UK. Diabetes in the UK in 2010: Key Statistics on Diabetes. http://www.diabetes.org.uk/Documents/Reports/Diabetes_in_the_UK_2010.pdf (accessed 29 Oct 2011).
2. The Renal Association. UK Renal Registry Twelfth Annual Report 2009. http://www.renalreg.com/Reports/2009.html (accessed 29 Oct 2011).
3. Hoffmann F, Haastert B, Koch M, et al. The effect of diabetes on incidence and mortality in end-stage renal disease in Germany. Nephrol Dial Transplant 2011;26:1634-40.
4. United States Renal Data System. USRDS 2010 Annual Data Report: Atlas of Chronic Kidney Disease and End-Stage Renal Disease in the United States. Bethesda, MD: National Institute of Diabetes and Digestive and Kidney Diseases, 2010.
5. Icks A, Haastert B, Gandjour A, et al. Costs of dialysisda regional population-based analysis. Nephrol Dial Transplant 2010;25:1647-52.
6. Baboolal K, McEwan P, Sondhi S, et al. The cost of renal dialysis in a UK settingda multicentre study. Nephrol Dial Transplant 2008;23:1982-9.
7. Department of Health. The National Service Framework for Renal Services. 2004.
8. Salifu MO, Abbott KC, Aytug S, et al. New-onset diabetes after hemodialysis initiation: impact on survival. Am J Nephrol 2010;31:239-46.
9. Chung SH, Noh H, Ha H, et al. Optimal use of peritoneal dialysis in patients with diabetes. Perit Dial Int 2008;29:S132-4.
10. Haapio M, Helve J, Groop PH, et al. Survival of patients with type 1 diabetes receiving renal replacement therapy in 1980-2007. Diabetes Care 2010;33: 1718-23.
11. Kervinen M, Lehto S, Ikäheimo R, et al. Improved survival of type 2 diabetic patients on renal replacement therapy in Finland. Nephrol Dial Transplant 2010;25:892-6.
12. Wolfe RA, Ashby VB, Milford EL, et al. Comparison of mortality in all patients on dialysis, patients on dialysis awaiting transplantation, and recipients of a first cadaveric transplant. N Engl J Med 1999;341:1725-30.
13. Trespalacios FC, Taylor AJ, Agodoa LY, et al. Incident acute coronary syndromes in chronic dialysis patients in the United States. Kidney Int 2002;62:1799-805.
14. Iseki K, Fukiyama K. Long-term prognosis and incidence of acute myocardial infarction in patients on chronic hemodialysis. The Okinawa Dialysis Study Group. Am J Kidney Dis 2000;36:820-5.
15. Le Feuvre C, Borentain M, Beygui F, et al. Comparison of short- and long-term outcomes of coronary angioplasty in patients with and without diabetes mellitus and with and without hemodialysis. Am J Cardiol 2003;92:721-5.
16. Momose M, Babazono T, Kondo C, et al. Prognostic significance of stress myocardial ECG-gated perfusion imaging in asymptomatic patients with diabetic chronic kidney disease on initiation of haemodialysis. Eur J Nucl Med Mol Imaging 2009;36:1315-21.
17. Sànchez-Perales C, Vázquez E, García-Cortès MJ, et al. Ischaemic stroke in incident dialysis patients. Nephrol Dial Transplant 2010;25:3343-8.
18. Davenport A, Cox C, Thuraisingham R. Blood pressure control and symptomatic intradialytic hypotension in diabetic haemodialysis patients: a cross-sectional survey. Nephron Clin Pract 2008;109:65-71.
19. Kato S, Chmielewski M, Honda H, et al. Aspects of immune dysfunction in end-stage renal disease. Clin J Am Soc Nephrol 2008;3:1526-33.
20. Ho LC, Wang HH, Chiang CK, et al. Malnutrition-inflammation score independently determined cardiovascular and infection risk in peritoneal dialysis patients. Blood Purif 2010;30:16-24.
21. Sarnak MJ, Jaber BL. Mortality caused by sepsis in patients with end-stage renal disease compared with the general population. Kidney Int 2000;58:1758-64.
22. Jaar BG, Hermann JA, Furth SL, et al. Septicemia in diabetic hemodialysis patients: comparison of incidence, risk factors, and mortality with nondiabetic hemodialysis patients. Am J Kidney Dis 2000;35:282-92.
23. Abbott AC, Agodoa LY. Etiology of bacterial septicaemia in chronic dialysis patients in the United States. Clin Nephrol 2001;56:124-31.
24. Papanas N, Liakopoulos V, Maltezos E, et al. The diabetic foot in end stage renal disease. Ren Fail 2007;29:519-28.
25. Ndip A, Rutter MK, Vileikyte L, et al. Dialysis treatment is an independent risk factor for foot ulceration in patients with diabetes and stage 4 or 5 chronic kidney disease. Diabetes Care 2010;33:1811-16.
26. Combe C, Albert JM, Bragg-Gresham JL, et al. The burden of amputation among hemodialysis patients in the Dialysis Outcomes and Practice Patterns Study (DOPPS). Am J Kidney Dis 2009;54:680-92.
27. Plakogiannis R. Vascular complications of the lower extremities in diabetic patients on peritoneal dialysis. Clin Nephrol 2008;69:361-367.
28. Lavery LA, Hunt NA, Ndip A, et al. Impact of chronic kidney disease on survival after amputation in individuals with diabetes. Diabetes Care 2010;33:2365-9.
29. Abularrage CJ, Conrad MF, Hackney LA, et al. Long-term outcomes of diabetic patients undergoing endovascular infrainguinal interventions. J Vasc Surg 2010;52:314-22.
30. Faglia E, Clerici G, Clerissi J, et al. Long term prognosis of diabetic patients with critical limb ischaemia: a population-based cohort study. Diabetes Care 2009;32:822-7.
31. Watanabe Y, Yuzawa Y, Mizumoto D, et al. Long term follow up study of 268 diabetic patients undergoing haemodialysis, with special attention to visual acuity and heterogeneity. Nephrol Dial Transplant 1993;8:725-34.
32. Diskin CJ, Stokes TJ, Dansby LM, et al. A hypothesis: can erythropoietin administration affect the severity of retinopathy in diabetic patients with renal failure? Am J Med Sci 2007;334:260-4.
33. Monroy-Cuadros M, Yilmaz S, Salazar-Bañuelos A, et al. Risk factors associated with patency loss of hemodialysis vascular access within 6 months. Clin J Am Soc Nephrol 2010;5:1787-92.
34. Wu CC, Wen SC, Yang CW, et al. Baseline plasma glycemic profiles but not inflammatory biomarkers predict symptomatic restenosis after angioplasty of arteriovenous fistulas in patients with hemodialysis. Atherosclerosis 2009;209:598-600.
35. Little MA, O'Riordan A, Lucey B, et al. A prospective study of complications associated with cuffed, tunnelled haemodialysis catheters. Nephrol Dial Transplant 2001;16:2194-200.
36. Drayer RA, Piraino B, Reynolds CF, et al. Characteristics of depression in hemodialysis patients: symptoms, quality of life and mortality risk. Gen Hosp Psychiatry 2006;28:306-12.
37. Sørensen VR, Mathiesen ER, Watt T, et al. Diabetic patients treated with dialysis: complications and quality of life. Diabetologia 2007;50:2254-62.
38. Martínez-Castelao A, Górriz JL, Garcia-López F, et al; Spanish CALVIDIA Study Group. Perceived health-related quality of life and comorbidity in diabetic patient starting dialysis (CALVIDIA study). J Nephrol 2004;17:544-51.
39. Ahola AJ, Saraheimo M, Forsblom C, et al; FinnDiane Study Group. Health-related quality of life in patients with type 1 diabetesdassociation with diabetic complications (the FinnDiane Study). Nephrol Dial Transplant 2010;25:1903-8.
40. Ghavamian M, Gutch CF, Kopp KF, et al. The sad truth about haemodialysis in diabetic nephropathy. JAMA 1972;222:1386-9.
41. The Renal Association. Detection, Monitoring and Care of Patients with CKD. http://www.renal.org/Clinical/GuidelinesSection/Detection-Monitoring-and-Care-of-Patients-with-CKD.aspx (accessed 15 Jun 2011).
42. Anon. JBS 2: Joint British Societies' guidelines on prevention of cardiovascular disease in clinical practice. Heart 2005;91(Suppl V):v1-v52.
43. NICE guideline CG66 type 2 diabetes: national clinical guideline for management in primary and secondary care (update). 2008. http://www.nice.org.uk/nicemedia/live/11983/40803/40803.pdf (accessed 15 Jun 2011).
44. Zoungas S, Kerr PG, Lui M, et al. The impact of glycaemic control on outcomes in patients with end-stage renal disease and type 2 diabetes. Nephrology 1997;13:124-7.
45. Morioka T, Emoto M, Tabata T, et al. Glycaemic control is a predictor of survival for diabetic patients on haemodialysis. Diabetes Care 2001;24:909-13.
46. Oomichi T, Emoto M, Tabata T, et al. Impact of glycaemic control on survival of diabetic patients on chronic regular haemodialysis. Diabetes Care 2006;29:1496-500.
47. Wu MS, Yu CC, Yang CW, et al. Poor pre dialysis glycaemic control is a predictor of mortality in type II diabetic patients on maintenance haemodialysis. Nephrol Dial Transplant 1997;12:2105-10.
48. Yu CC, Wu MS, Wu CH, et al. Predialysis glycemic control is an independent predictor of clinical outcome in type II diabetics on continuous ambulatory peritoneal dialysis. Perit Dial Int 1997;17:262-8.
49. Shurraw S, Majumdar SR, Thadhani R, et al; Alberta Kidney Disease Network. Glycemic control and the risk of death in 1,484 patients receiving maintenance haemodialysis. Am J Kidney Dis 2010;55:875-84.
50. Williams ME, Lacson E, Wang W, et al. Glycemic control and extended hemodialysis survival in patients with diabetes mellitus: comparative results of traditional and time-dependent Cox model analyses. Clin J Am Soc Nephrol 2010;5:1595-601.
51. Gerstein HC, Miller ME, Byington RP, et al; Action to Control Cardiovascular Risk in Diabetes Study Group. Effects of intensive glucose lowering in type 2 diabetics. N Engl J Med 2008;358:2545-59.
52. Drechsler C, Krane V, Ritz E, et al. Glycemic control and cardiovascular events in diabetic hemodialysis patients. Circulation 2009;120:2421-8.
53. Tsujimoto Y, Ishimura E, Tahara H, et al. Poor glycaemic control is a significant predictor of cardiovascular events in chronic haemodialysis patients with diabetes. Ther Apher Dial 2009;13:358-65.
54. Mehmet S, Quan G, Thomas S, et al. Important causes of hypoglycaemia in patients on peritoneal dialysis. Diabet Med 2001;18:679-682.
55. Marshall J, Jennings P, Scott A, et al. Glycemic control in diabetic CAPD patients assessed by continuous glucose monitoring system (CGMS). Kidney Int 2003;64:1480-6.
56. Skubala A, Zywiec J, Zełobowska K, et al. Continuous glucose monitoring system in 72-hour glucose profile assessment in patients with end-stage renal disease on maintenance continuous ambulatory peritoneal dialysis. Mel Sci Mon 2010;16: CR75-CR83.
57. Sobngwi E, Ashuntantang G, Ndounia E, et al. Continuous interstitial glucose monitoring in non-diabetic subjects with end-stage renal disease undergoing maintenance haemodialysis. Diabetes Res Clin Pract 2010;90:22-5.
58. Riveline JP, Teynie J, Belmouaz S, et al. Glycaemic control in type 2 diabetic patients on chronic haemodialysis: use of a continuous glucose monitoring system. Nephrol Dial Transplant 2009;24:2866-2871.
59. Kazempour-Ardebili S, Lecamwasam VL, Dassanyake T, et al. Assessing glycemic control in maintenance haemodialysis patients with Type 2 diabetes. Diabetes Care 2009;32:1137-42.
60. British National Formulary. 2011. http://www.vhn.net/bnf.html (accessed 29 Oct 2011).
61. Peacock TP, Shihabi ZK, Bleyer AJ, et al. Comparison of glycared albumin and hemoglobin A(1c) levels in diabetic subjects on hemodialysis. Kidney Int 2008;73:1062-8.
62. Mittman N, Desiraju B, Fazil I, et al. Serum fructosamine versus glycosylated hemoglobin as an index of glycemic control, hospitalization, and infection in diabetic hemodialysis patients. Kidney Int Suppl 2010;117:S41-S45. http://www.glucosesafety.com/ph/downloads/add_links/Country-Specific_Glucose_Monitor_List.pdf (accessed 29 Oct 2011).
63. Pera IP, Vasallo MJ. Quality of life in simultaneous pancreas-kidney transplant recipients. Clin Transplant 2009;23:600-5.
64. Sollinger HW, Odorico JS, Becker YT, et al. One thousand simultaneous pancreas-kidney transplants at a single center with 22-year follow-up. Ann Surg 2009;250:618-30.
65. Ramirez SP, Albert JM, Blayney MJ, et al. Rosiglitazone is associated with mortality in chronic hemodialysis patients. J Am Soc Nephrol 2009;20:1094-101.
66. Abe M, Okada K, Maruyama T, et al. Combination therapy with mitiglinide and voglibose improves glycemic control in type 2 diabetic patients on hemodialysis. Expert Opin Pharmacother 2010;11:169-76.
67. Sobngwi E, Enoru S, Ashuntantang G, et al. Day-to-day variation of insulin requirements of patients with type 2 diabetes and end-stage renal disease undergoing maintenance hemodialysis. Diabetes Care 2010;33:1409-12.
68. Joss N, Paterson KR, Deighan CJ, et al. Diabetic nephropathy: how effective is treatment in clinical practice? QJM 2002;95:41-9.
69. Shipman KE, Patel CK. The effect of combined renal and pancreatic transplantation on diabetic retinopathy. Clin Ophthalmol 2009;3:531-5.
70. Ndip A, Lavery LA, Lafontaine J, et al. High levels of foot ulceration and amputation risk in a multiracial cohort of diabetic patients on dialysis therapy. Diabetes Care 2010;33:878-80.
71. Ndip A, Lavery LA, Boulton AJ. Diabetic foot disease in people with advanced nephropathy and those on renal dialysis. Curr Diab Rep 2010;10:283-90.
72. Lipscombe J, Jassal SV, Bailey S, et al. Chiropody may prevent amputations in diabetic patients on peritoneal dialysis. Perit Dial Int 2003;23:255-9.
73. McMurray SD, Johnson G, Davis S, et al. Diabetes education and care management significantly improve patient outcomes in the dialysis unit. Am J Kidney Dis 2002;40:566-75.
74. Ooi DS, House AA. Cardiac troponin T in hemodialzed patients. Clin Chem 1998;44:1410-16.
75. Fellström BC, Jardine AG, Schmieder RE, et al. Rosuvastatin and cardiovascular events in patients undergoing hemodialysis. N Engl J Med 2009;360:1395-407.